154 related articles for article (PubMed ID: 31437115)
21. Significant prognostic factors for completely resected pN2 non-small cell lung cancer without neoadjuvant therapy.
Uehara H; Nakao M; Mun M; Nakagawa K; Nishio M; Ishikawa Y; Okumura S
Ann Thorac Cardiovasc Surg; 2015; 21(4):345-53. PubMed ID: 25740454
[TBL] [Abstract][Full Text] [Related]
22. [Postoperative survival analysis of patients with stage Ⅲ-pN2 non-small cell lung cancer].
Wu XW; Chen T; Yin S; Deng Y; Zhao B
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):782-786. PubMed ID: 30392344
[No Abstract] [Full Text] [Related]
23. Prognostic Factors for Surgically Resected N2 Non-small Cell Lung Cancer.
Kawasaki K; Sato Y; Suzuki Y; Saito H; Nomura Y; Yoshida Y
Ann Thorac Cardiovasc Surg; 2015; 21(3):217-22. PubMed ID: 25641029
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcomes of thoracoscopic lobectomy for patients with clinical N0 and pathologic N2 non-small cell lung cancer.
Zhong C; Yao F; Zhao H
Ann Thorac Surg; 2013 Mar; 95(3):987-92. PubMed ID: 23261117
[TBL] [Abstract][Full Text] [Related]
25. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
Matsunaga T; Suzuki K; Takamochi K; Oh S
Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
[TBL] [Abstract][Full Text] [Related]
26. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
[TBL] [Abstract][Full Text] [Related]
28. Incidence, Risk Factors, and Analysis of Survival of Unexpected N2 Disease in Stage I Non-Small Cell Lung Cancer.
Fiorelli A; Sagan D; Mackiewicz L; Cagini L; Scarnecchia E; Chiodini P; Caronia FP; Puma F; Santini M; Ragusa M
Thorac Cardiovasc Surg; 2015 Oct; 63(7):558-67. PubMed ID: 25629458
[TBL] [Abstract][Full Text] [Related]
29. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH
Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905
[TBL] [Abstract][Full Text] [Related]
30. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
[TBL] [Abstract][Full Text] [Related]
32. Mediastinal Up-Staging During Surgery in Non-Small-Cell Lung Cancer: Which Mediastinal Lymph Node Metastasis Patterns Better Predict The Outcome? A Multicenter Analysis.
Chiappetta M; Leuzzi G; Sperduti I; Bria E; Mucilli F; Lococo F; Filosso PL; Ratto GB; Spaggiari L; Facciolo F
Clin Lung Cancer; 2020 Sep; 21(5):464-471.e1. PubMed ID: 32389508
[TBL] [Abstract][Full Text] [Related]
33. Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer.
Toosi K; Velez-Cubian FO; Glover J; Ng EP; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
Surgery; 2016 Nov; 160(5):1211-1218. PubMed ID: 27665362
[TBL] [Abstract][Full Text] [Related]
34. Survival impact of node zone classification in resected pathological N2 non-small cell lung cancer.
Baba T; Uramoto H; Kuwata T; Chikaishi Y; Nakagawa M; So T; Hanagiri T; Tanaka F
Interact Cardiovasc Thorac Surg; 2012 Jun; 14(6):760-4. PubMed ID: 22374294
[TBL] [Abstract][Full Text] [Related]
35. Long-term survival after complete mediastinal lymph node resection and lobectomy in patients with bulky N2 non-small cell lung cancer.
Sakuraba M; Takahashi N; Oh S; Miyasaka Y; Inagaki T; Suzuki K
Ann Thorac Cardiovasc Surg; 2011; 17(2):124-9. PubMed ID: 21597408
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of bulky swollen lymph nodes in cN1 non-small cell lung cancer patients.
Samejima J; Nakao M; Matsuura Y; Uehara H; Mun M; Nakagawa K; Motoi N; Masuda M; Ishikawa Y; Okumura S
Jpn J Clin Oncol; 2015 Nov; 45(11):1050-4. PubMed ID: 26355162
[TBL] [Abstract][Full Text] [Related]
37. Skip mediastinal nodal metastases in the IIIa/N2 non-small cell lung cancer.
Ilic N; Petricevic A; Arar D; Kotarac S; Banovic J; Ilic NF; Tripkovic A; Grandic L
J Thorac Oncol; 2007 Nov; 2(11):1018-21. PubMed ID: 17975493
[TBL] [Abstract][Full Text] [Related]
38. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Eur J Cardiothorac Surg; 2019 Nov; 56(5):849-857. PubMed ID: 31168596
[TBL] [Abstract][Full Text] [Related]
39. Postoperative long-term survival of non-small cell lung cancer patients with skip-N2 metastases.
Schlachtenberger G; Doerr F; Menghesha H; Heldwein MB; Hagmeyer L; Michel M; Schaefer SC; Wahlers T; Hekmat K
Surg Oncol; 2021 Sep; 38():101505. PubMed ID: 33901730
[TBL] [Abstract][Full Text] [Related]
40. Non-Small Cell Lung Cancer With N1 Involvement or Skip Metastases Presents the Same Survival Outcome: Results From a Multicentric Study.
Chiappetta M; Sassorossi C; Lococo F; Sperduti I; Mucilli F; Lyberis P; Ratto G; Spaggiari L; Gallina F; Facciolo F; Margaritora S
Clin Lung Cancer; 2023 Nov; 24(7):e275-e281. PubMed ID: 37481338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
